Manganese superoxide dismutase induces p53-dependent senescence in colorectal cancer cells

被引:92
作者
Behrend, L
Mohr, A
Dick, T
Zwacka, RM
机构
[1] Univ Ulm, Div Gene Therapy, D-89081 Ulm, Germany
[2] Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland
关键词
D O I
10.1128/MCB.25.17.7758-7769.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mitochondrial enzyme manganese superoxide dismutase (MnSOD) is known to suppress cell growth in different tumor cell lines. However, the molecular mechanism of this growth-retarding effect is not fully understood. Here we show that overexpression of MnSOD slows down growth of HCT116 human colorectal cancer cells by induction of cellular senescence. MnSOD overexpression causes up-regulation of p53 and its transcriptional target, the cyclin-dependent kinase inhibitor p21. Adenovirus-mediated knockdown of p53 by RNA interference rescues MnSOD-overexpressing clones from growth retardation. Accordingly, the overexpression of MnSOD in HCTp53(-/-) cells does not lead to senescence, whereas in HCTp21(-/-) cells we found induction of senescence by forced expression of MnSOD. These results indicate a pivotal role of p53, but not p21, in the observed effects. Analysis of the mitochondrial membrane potential revealed reduced polarization in MnSOD-overexpressing cells. In addition, depolarization of the mitochondrial membrane by mitochondrial inhibitors such as rotenone or antimycin A led colorectal cancer cells into p53-dependent senescence. Our data indicate that uncoupling of the electrochemical gradient by increased MnSOD activity gives rise to p53 up-regulation and induction of senescence. This novel mitochondrially mediated mechanism of tumor suppression might enable strategies that allow reactivation of cellular aging in tumor cells.
引用
收藏
页码:7758 / 7769
页数:12
相关论文
共 52 条
  • [31] Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells
    Psyrri, A
    DeFilippis, RA
    Edwards, APB
    Yates, KE
    Manuelidis, L
    DiMaio, D
    [J]. CANCER RESEARCH, 2004, 64 (09) : 3079 - 3086
  • [32] Mitochondrial dysfunction in lymphocytes from old mice: Enhanced activation of the permeability transition
    Rottenberg, H
    Wu, SL
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 240 (01) : 68 - 74
  • [33] SERUM MANGANESE SUPEROXIDE-DISMUTASE IS A NEW TUMOR-MARKER FOR MALIGNANT-MELANOMA
    SCHADENDORF, D
    ZUBERBIER, T
    DIEHL, S
    SCHADENDORF, C
    CZARNETZKI, BM
    [J]. MELANOMA RESEARCH, 1995, 5 (05) : 351 - 353
  • [34] Senescence apoptosis and therapy - cutting the lifelines of cancer
    Schmitt, CA
    [J]. NATURE REVIEWS CANCER, 2003, 3 (04) : 286 - 295
  • [35] Schmitt H, 2002, DEUT Z SPORTMED, V53, P6
  • [36] Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16(INK4a)
    Serrano, M
    Lin, AW
    McCurrach, ME
    Beach, D
    Lowe, SW
    [J]. CELL, 1997, 88 (05) : 593 - 602
  • [37] A ROLE FOR BOTH RB AND P53 IN THE REGULATION OF HUMAN CELLULAR SENESCENCE
    SHAY, JW
    PEREIRASMITH, OM
    WRIGHT, WE
    [J]. EXPERIMENTAL CELL RESEARCH, 1991, 196 (01) : 33 - 39
  • [38] P21(WAF1) mutations and human malignancies
    Shiohara, M
    Koike, K
    Komiyama, A
    Koeffler, HP
    [J]. LEUKEMIA & LYMPHOMA, 1997, 26 (1-2) : 35 - 41
  • [39] ALTERED GROWTH OF HUMAN COLON CANCER CELL-LINES DISRUPTED AT ACTIVATED KI-RAS
    SHIRASAWA, S
    FURUSE, M
    YOKOYAMA, N
    SASAZUKI, T
    [J]. SCIENCE, 1993, 260 (5104) : 85 - 88
  • [40] Reduced mitochondrial membrane potential and altered responsiveness of a mitochondrial membrane megachannel in p53-induced senescence
    Sugrue, MM
    Wang, Y
    Rideout, HJ
    Chalmers-Redman, RME
    Tatton, WG
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (01) : 123 - 130